What We Do
Julphar is one of the largest pharmaceutical manufacturers in the Middle East and Africa and one of the leading producers of insulin in the world.
The company was established in 1980 under the guidance of Sheikh Saqr Bin Mohammed Al Qasimi, the late ruler of Ras Al Khaimah, and since then Julphar has been delivering high quality, innovative and affordable healthcare solutions to families across the globe.
Our business is centered on three core business units – Julphar Diabetes Solutions, General Medicines and our consumer division. Our medicines target major therapeutic segments including Gastrointestinal Tract (GIT), Respiratory, Pain Management, Wounds and Scars, Anti-infectives, Anemia, Gynecology, Dermatology, Erectile Dysfunction and Cardiology.
We employ around 2,500 people and distribute our products to more than 50 countries on five continents. Our 12 internationally accredited facilities in the Middle East, produce one million boxes of medicine a day. In 2012, we became one of the world’s largest producers of insulin thanks to our state-of-the-art UAE-based biotechnology facility.